G. Mountzios

机构：Henry Dunant Hospital, Athens State University

发表论文 8 篇 · 总被引 16 次 · h-index 2

代表论文

• VP4-2023: Sotorasib 960 mg versus 240 mg in pretreated KRAS G12C advanced NSCLC (2023 · Annals of Oncology · 被引 13)
• P3.18.80 A Phase 3 Study of Sacituzumab Govitecan in Patients With Previously Treated Extensive Stage Small Cell Lung Cancer (2025 · Journal of Thoracic Oncology · 被引 2)
• 13P: Brain metastases and actionable genetic alterations with sacituzumab govitecan versus docetaxel in metastatic non-small cell lung cancer: Subgroups of the phase III EVOKE-01 trial (2025 · Journal of Thoracic Oncology · 被引 1)
• PT2.15.02 Young Lung Cancer: The Psychosocial Needs Assessment (2025 · Journal of Thoracic Oncology)
• P3.12.13 Long-Term Real-World Outcomes of Sotorasib in Second-Line and Beyond Treatment of KRAS G12C-Mutated Advanced NSCLC (2025 · Journal of Thoracic Oncology)
• 1952P Long-term safety profile of sacituzumab govitecan (SG) vs docetaxel in patients (Pts) with metastatic non-small cell lung cancer (mNSCLC) from EVOKE-01 (2025 · Annals of Oncology)